S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibition
L. R. Begg, A. M. Orriols, M. Zannikou, C. Yeh, P. Vadlamani, D. Kanojia, R. Bolin, S. F. Dunne, S. Balakrishnan, R. Camarda, D. Roth, N. A. Zielinski-Mozny, C. Yau, A. Vassilopoulos, T.-H. Huang, , D. Horiuchi
bioRxiv · Sep 21, 2023 · PreprintCancer Biology